Bollard Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-200	Closed	-$14K	–	265
2018 Q4	$14K	Hold	200	–	–	﹤0.01%	239
2018 Q3	$25K	Buy	+200	New	+$25K	﹤0.01%	230